Daiwa Securities Group
BIIB icon

Daiwa Securities Group’s Biogen BIIB Stock Holding History

Daiwa Securities Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.97M Buy
27,136
+859
+3% +$158K 0.01% 463
2025
Q4 		$4.62M Sell
26,277
-17,798
-40% -$2.91M 0.01% 476
2025
Q3 		$6.17M Buy
44,075
+4,947
+13% +$669K 0.02% 401
2025
Q2 		$4.91M Sell
39,128
-4,265
-10% -$531K 0.02% 434
2025
Q1 		$5.94M Buy
43,393
+6,172
+17% +$882K 0.03% 367
2024
Q4 		$5.69M Buy
37,221
+5,627
+18% +$949K 0.03% 363
2024
Q3 		$6.12M Buy
31,594
+6,746
+27% +$1.41M 0.03% 328
2024
Q2 		$5.76M Buy
24,848
+2,197
+10% +$477K 0.03% 308
2024
Q1 		$4.88M Buy
22,651
+2,172
+11% +$509K 0.03% 331
2023
Q4 		$5.3M Sell
20,479
-4,835
-19% -$1.19M 0.03% 286
2023
Q3 		$6.87M Buy
25,314
+6,677
+36% +$1.79M 0.05% 208
2023
Q2 		$5.31M Buy
18,637
+508
+3% +$151K 0.04% 263
2023
Q1 		$5.04M Buy
18,129
+1,859
+11% +$514K 0.04% 272
2022
Q4 		$4.5M Buy
16,270
+416
+3% +$117K 0.03% 284
2022
Q3 		$4.23M Buy
15,854
+747
+5% +$159K 0.04% 278
2022
Q2 		$3.44M Buy
15,107
+708
+5% +$145K 0.03% 323
2022
Q1 		$3.42M Buy
14,399
+927
+7% +$202K 0.02% 362
2021
Q4 		$3.48M Buy
13,472
+545
+4% +$140K 0.02% 365
2021
Q3 		$3.66M Buy
12,927
+683
+6% +$224K 0.02% 325
2021
Q2 		$4.24M Sell
12,244
-4,667
-28% -$1.41M 0.03% 278
2021
Q1 		$4.73M Buy
16,911
+5,058
+43% +$1.36M 0.04% 217
2020
Q4 		$2.9M Buy
11,853
+27
+0.2% +$6.96K 0.02% 309
2020
Q3 		$3.35M Buy
11,826
+637
+6% +$178K 0.03% 236
2020
Q2 		$3.77M Hold
11,189
– – 0.08% 133
2020
Q1 		$3.54M Buy
11,189
+1,391
+14% +$422K 0.04% 214
2019
Q4 		$2.91M Sell
9,798
-140
-1% -$38.8K 0.02% 272
2019
Q3 		$2.31M Buy
9,938
+1,368
+16% +$319K 0.02% 314
2019
Q2 		$2M Sell
8,570
-1,287
-13% -$297K 0.02% 334
2019
Q1 		$2.33M Sell
9,857
-2,256
-19% -$710K 0.02% 310
2018
Q4 		$3.65M Sell
12,113
-5,712
-32% -$1.82M 0.04% 225
2018
Q3 		$6.3M Buy
17,825
+7,970
+81% +$2.74M 0.05% 183
2018
Q2 		$2.86M Buy
9,855
+280
+3% +$78.7K 0.02% 318
2018
Q1 		$2.62M Buy
9,575
+1,625
+20% +$504K 0.02% 328
2017
Q4 		$2.53M Buy
7,950
+144
+2% +$46.2K 0.02% 343
2017
Q3 		$2.44M Buy
7,806
+1,576
+25% +$467K 0.02% 311
2017
Q2 		$1.69M Sell
6,230
-19,480
-76% -$5.15M 0.01% 354
2017
Q1 		$7.03M Buy
25,710
+171
+0.7% +$48.4K 0.04% 167
2016
Q4 		$7.24M Buy
25,539
+8,239
+48% +$2.44M 0.05% 129
2016
Q3 		$5.42M Buy
17,300
+50
+0.3% +$14.8K 0.03% 159
2016
Q2 		$4.17M Buy
17,250
+5,400
+46% +$1.42M 0.02% 189
2016
Q1 		$3.08M Buy
11,850
+6,470
+120% +$1.71M 0.02% 221
2015
Q4 		$1.65M Sell
5,380
-22,500
-81% -$6.47M 0.01% 283
2015
Q3 		$8.14M Sell
27,880
-9,770
-26% -$3.23M 0.06% 125
2015
Q2 		$15.2M Buy
37,650
+19,100
+103% +$7.67M 0.11% 84
2015
Q1 		$7.83M Buy
18,550
+3,850
+26% +$1.52M 0.05% 129
2014
Q4 		$4.99M Buy
14,700
+8,570
+140% +$2.77M 0.04% 157
2014
Q3 		$2.03M Sell
6,130
-100
-2% -$33K 0.02% 218
2014
Q2 		$1.96M Sell
6,230
-300
-5% -$90.3K 0.01% 222
2014
Q1 		$2M Hold
6,530
– – 0.02% 225
2013
Q4 		$1.83M Sell
6,530
-600
-8% -$155K 0.02% 203
2013
Q3 		$1.72M Hold
7,130
– – 0.01% 225
2013
Q2 		$1.53M Buy
+7,130
New +$1.52M 0.01% 238

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Daiwa Securities Group's BIIB Position: Q1 2026 in Review

Daiwa Securities Group increased its Biogen (BIIB) stake by 3.3% in Q1 2026, buying an estimated $158K and bringing the position to 27,136 shares worth $4.97M. The position accounts for 0.01% of the portfolio, ranked #463.

Daiwa Securities Group first reported a position in BIIB in Q2 2013 and has held it in 52 quarters since. The position peaked at $15.2M in Q2 2015. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Daiwa Securities Group held 27,136 shares of Biogen worth $4.97M as of Q1 2026.
  • Daiwa Securities Group bought 859 Biogen shares in Q1 2026, an estimated $158K.
  • Biogen made up 0.01% of Daiwa Securities Group's portfolio in Q1 2026, its #463 holding.
  • Daiwa Securities Group first reported a position in Biogen in Q2 2013 and has held it in 52 quarters since.
  • Daiwa Securities Group's Biogen position peaked at $15.2M in Q2 2015.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.